A detailed history of Fifth Third Bancorp transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 527 shares of LNTH stock, worth $48,831. This represents 0.0% of its overall portfolio holdings.

Number of Shares
527
Previous 479 10.02%
Holding current value
$48,831
Previous $38,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$77.7 - $123.62 $3,729 - $5,933
48 Added 10.02%
527 $57,000
Q2 2024

Jul 22, 2024

BUY
$58.87 - $83.05 $2,119 - $2,989
36 Added 8.13%
479 $38,000
Q1 2024

Apr 23, 2024

BUY
$51.07 - $68.26 $3,268 - $4,368
64 Added 16.89%
443 $27,000
Q4 2023

Jan 19, 2024

BUY
$55.6 - $77.89 $9,118 - $12,773
164 Added 76.28%
379 $23,000
Q3 2023

Oct 31, 2023

SELL
$60.27 - $90.75 $1,567 - $2,359
-26 Reduced 10.79%
215 $14,000
Q2 2023

Jul 25, 2023

BUY
$82.41 - $99.65 $2,801 - $3,388
34 Added 16.43%
241 $20,000
Q1 2023

Apr 24, 2023

BUY
$47.76 - $82.86 $907 - $1,574
19 Added 10.11%
207 $17,000
Q4 2022

Jan 25, 2023

BUY
$48.76 - $77.67 $1,804 - $2,873
37 Added 24.5%
188 $0
Q2 2022

Aug 04, 2022

BUY
$55.54 - $72.65 $1,555 - $2,034
28 Added 22.76%
151 $10,000
Q1 2022

Apr 19, 2022

BUY
$24.28 - $56.64 $2,986 - $6,966
123 New
123 $7,000
Q4 2021

Feb 01, 2022

SELL
$22.54 - $30.44 $1,780 - $2,404
-79 Closed
0 $0
Q3 2021

Oct 15, 2021

SELL
$24.23 - $28.59 $35,642 - $42,055
-1,471 Reduced 94.9%
79 $2,000
Q2 2021

Aug 06, 2021

SELL
$19.51 - $27.64 $28,718 - $40,686
-1,472 Reduced 48.71%
1,550 $43,000
Q1 2021

May 07, 2021

BUY
$13.77 - $21.66 $21,343 - $33,573
1,550 Added 105.3%
3,022 $65,000
Q2 2020

Aug 05, 2020

BUY
$10.34 - $15.51 $15,220 - $22,830
1,472 New
1,472 $21,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.37B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.